Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
KIMS already have a multi-specialty hospital and gastro unit at Vizag
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The company plans to add 1700 beds by FY27 through the organic route
Subscribe To Our Newsletter & Stay Updated
